|Videos|December 1, 2020
Test Real-World Evidence: Real World Uses and the Regulatory Vision Forward
Author(s)Parexel
Advertisement
Pharm Exec’s Lisa Henderson, Scott Gottlieb, MD, Former FDA Commissioner, and experts from Parexel talk about the COVID-19 pandemic and how its enormous impact on our medical systems has accelerated the growth in and adoption of RWE.
A New Era of Real-World Evidence
Breaking New Ground with RWE
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX
2
FDA Continues to Expand National Priority Voucher Program
3
FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma
4
Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?
5
